EVERY urges court to sanction Onego Bio as alt protein IP fight turns nasty
EVERY accuses Onego Bio of abusive litigation tactics; Onego says the evidence contradicts sworn statements by EVERY executives.
EVERY accuses Onego Bio of abusive litigation tactics; Onego says the evidence contradicts sworn statements by EVERY executives.
“To our knowledge, we are the only fermentation derived emulsifier portfolio platform in the world,” says CTO Pavan Kambam.